BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1786990)

  • 1. Characterization of the C5a receptor on guinea pig platelets.
    Kretzschmar T; Kahl K; Rech K; Bautsch W; Köhl J; Bitter-Suermann D
    Immunobiology; 1991 Nov; 183(5):418-32. PubMed ID: 1786990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of C3a receptor-proteins on guinea pig platelets and human polymorphonuclear leukocytes.
    Gerardy-Schahn R; Ambrosius D; Saunders D; Casaretto M; Mittler C; Karwarth G; Görgen S; Bitter-Suermann D
    Eur J Immunol; 1989 Jun; 19(6):1095-102. PubMed ID: 2666143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant human C5a-induced bronchoconstriction in the guinea pig: inhibition by an H1 antagonist after depletion of circulating granulocytes and platelets.
    Fraser DG; Regal JF
    J Pharmacol Exp Ther; 1991 Dec; 259(3):1213-20. PubMed ID: 1684819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Demonstration of a specific C3a receptor on guinea pig platelets.
    Fukuoka Y; Hugli TE
    J Immunol; 1988 May; 140(10):3496-501. PubMed ID: 3283237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A recombinant hybrid anaphylatoxin with dual C3a/C5a activity.
    Bautsch W; Kretzschmar T; Stühmer T; Kola A; Emde M; Köhl J; Klos A; Bitter-Suermann D
    Biochem J; 1992 Nov; 288 ( Pt 1)(Pt 1):261-6. PubMed ID: 1445269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of a C5a receptor on human polymorphonuclear leukocytes (PMN).
    Huey R; Hugli TE
    J Immunol; 1985 Sep; 135(3):2063-8. PubMed ID: 4020139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet-serotonin release by C3a and C5a: two independent pathways of activation.
    Meuer S; Ecker U; Hadding U; Bitter-Suermann D
    J Immunol; 1981 Apr; 126(4):1506-9. PubMed ID: 7204973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of an antigenic epitope and receptor binding domain of human C5a.
    Johnson RJ; Tamerius JD; Chenoweth DE
    J Immunol; 1987 Jun; 138(11):3856-62. PubMed ID: 2438329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stabilization of C5a receptor--G-protein interactions through ligand binding.
    Wennogle LP; Conder L; Winter C; Braunwalder A; Vlattas S; Kramer R; Cioffi C; Hu SI
    J Cell Biochem; 1994 Jul; 55(3):380-8. PubMed ID: 7962171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Site-specific mutagenesis of residues in the human C5a anaphylatoxin which are involved in possible interaction with the C5a receptor.
    Bubeck P; Grötzinger J; Winkler M; Köhl J; Wollmer A; Klos A; Bautsch W
    Eur J Biochem; 1994 Feb; 219(3):897-904. PubMed ID: 8112341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma clearance of the human C5a anaphylatoxin by binding to leucocyte C5a receptors.
    Oppermann M; Götze O
    Immunology; 1994 Aug; 82(4):516-21. PubMed ID: 7835913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The generation of stable CHO cell lines expressing very high levels of complement C5A receptors and subsequent modulation of binding affinity for C5A.
    Pease JE; Burton DR; Barker MD
    Biochem Mol Biol Int; 1993 Feb; 29(2):339-47. PubMed ID: 8495216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probing the human receptor for C5a anaphylatoxin with site-directed antibodies. Identification of a potential ligand binding site on the NH2-terminal domain.
    Oppermann M; Raedt U; Hebell T; Schmidt B; Zimmermann B; Götze O
    J Immunol; 1993 Oct; 151(7):3785-94. PubMed ID: 8376805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-linked glycosylation of the C5a receptor.
    Pease JE; Barker MD
    Biochem Mol Biol Int; 1993 Nov; 31(4):719-26. PubMed ID: 8298500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification of the active C5a receptor from human polymorphonuclear leukocytes as a receptor-Gi complex.
    Rollins TE; Siciliano S; Kobayashi S; Cianciarulo DN; Bonilla-Argudo V; Collier K; Springer MS
    Proc Natl Acad Sci U S A; 1991 Feb; 88(3):971-5. PubMed ID: 1899485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship of C5a receptor modulation to the functional responsiveness of human polymorphonuclear leukocytes to C5a.
    Van Epps DE; Simpson SJ; Johnson R
    J Immunol; 1993 Jan; 150(1):246-52. PubMed ID: 8417126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C3a induced activation and stimulus specific reversible desensitization of guinea pig platelets.
    Zanker B; Rasokat H; Hadding U; Bitter-Suermann D
    Agents Actions Suppl; 1982; 11():147-57. PubMed ID: 6983827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of a novel low affinity complement C3dg-binding protein of human platelets.
    Chen H; Marjan J; Cox AD; Devine DV
    J Immunol; 1994 Feb; 152(3):1332-8. PubMed ID: 8301135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cloning and characterization of the guinea pig C5a anaphylatoxin receptor: interspecies diversity among the C5a receptors.
    Fukuoka Y; Ember JA; Yasui A; Hugli TE
    Int Immunol; 1998 Mar; 10(3):275-83. PubMed ID: 9576615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-function studies in a series of carboxyl-terminal octapeptide analogues of anaphylatoxin C5a.
    Kawai M; Quincy DA; Lane B; Mollison KW; Or YS; Luly JR; Carter GW
    J Med Chem; 1992 Jan; 35(2):220-3. PubMed ID: 1732540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.